Mashup Score: 1 OncLive Dr. Muss on the Use of Metronomic Chemotherapy in Metastatic Breast Cancer - Hyman B. Muss, MD, discusses the use of metronomic chemotherapy in metastatic breast 1637212357800730628 OncLive.com WATCH: Hyman B. Muss, MD, of @UNC_Lineberger, discusses the use of metronomic chemotherapy in metastatic breast cancer. #bcsm https://t.co/XCaBkahSi7 - view on twitter More coverage: #bcsm Read the full article here See more from OncLive.com Share this article × facebook twitter email https://mashupmd.com/dr-muss-on-the-use-of-metronomic-chemotherapy-in-metastatic-breast-cancer/ Copy Link
Nature Durable responses in patients with HER2+ breast cancer and leptomeningeal metastas... #bcsm Dr Sarah Sammons
ascopost.com Lower-Dose Regimens of Exemestane in Postmenopausal Patients With Stage 0 to II ER... #bcsm #BreastCancer The ASCO Post
VJOncology Optimal neoadjuvant and adjuvant therapy for patients with early TNBC #bcsm #BreastCancer VJ Oncology
ascopost.com Change in Frailty Status Among Older Patients Undergoing Locoregional Therapy for ... #bcsm #BreastCancer The ASCO Post
Targeted Oncology Activity of Tovorafenib in Recurrent or Progressive Pediatric Low-Grade Glioma May... #bcsm #glioma Targeted Oncology
National Cancer Institute Breast Cancer Surgery’s Impact on Quality of Life #bcsm #BreastCancer National Cancer Institute
Targeted Oncology Updated HER2– Metastatic Breast Cancer Guideline Embraces Sacituzumab Govitecan #ASCO #bcsm Targeted Oncology
Medscape Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From... #bcsm #CME Medscape Oncology
VJOncology Long-term evidence for partial breast irradiation in early breast cancer #bcsm #BreastCancer VJ Oncology
www.jwatch.org NEJM Journal Watch: Summaries of and commentary on original medical and scientific... #bcsm Santhosh Ambika
OncLive Dr Sikov on the Benefit of CDK4/6 Inhibitors in HR+/HER2-Negative Breast Cancer #bcsm #oncology OncLive.com
ascopost.com New Prognostic Staging System for De Novo Metastatic Breast Cancer - The ASCO Post #bcsm #BreastCancer The ASCO Post
Cancer Network Post-Surgical Radiation Omission did not Raise Breast Cancer Distant Recurrence #bcsm CancerNetwork®
www.sciencedirect.com The prevalence and intensity of late effects in patients with testicular germ cell... #bcsm Oncology Advance
WATCH: Hyman B. Muss, MD, of @UNC_Lineberger, discusses the use of metronomic chemotherapy in metastatic breast cancer. #bcsm https://t.co/XCaBkahSi7 - view on twitter